Intellia Therapeutics reports positive data from the ongoing Phase 1/2 study of NTLA-2002, a CRISPR-based gene editing therapy, in patients with hered...
The Public Citizen Health Research Group calls for a federal investigation into clinical trials for two Alzheimers drugs that may have violated inform...
Baxter Healthcare recalls (Class 1) its Life2000 ventilator to update the use instructions after finding that the device may fail to issue a low gas p...
Pfizer submits pages of recommended changes to an FDA draft guidance on incorporating voluntary patient preference information over a medical devices ...
Researchers from Case Western Reserve University School of Medicine report that semaglutide may reduce the risk of Alzheimer's disease in people with ...
The American Society of Health-System Pharmacists says there were 277 drug shortages as of September, down from an all-time high of 323.
An FDA safety alert warns about Regener-Eyes manufactured by Regenerative Processing Plant because the eye drops likely contain amniotic fluid.
FDA accepts for priority review a Telix NDA for Pixclara (18F-floretyrosine), a positron emission tomography agent for glioma imaging.
